Silexion Therapeutics - Warrants(14/08/2029) Accounts Payable

As of the most recent data (June 2026), SLXNW shows a accounts payable of $1.2M. That compares with $690K in the prior-year period — up 70.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SLXNW's accounts payable is now $1.2M (was $690K) — a 70.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Silexion Therapeutics - Warrants(14/08/2029) is outperforming or lagging.

Tracking SLXNW's accounts payable over time shows whether Silexion Therapeutics - Warrants(14/08/2029) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.2M That compares with $690K in the prior-year period — up 70.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Silexion Therapeutics - Warrants(14/08/2029)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $1.2M) with ownership activity and broader fundamentals.